This topic contains a solution. Click here to go to the answer

Author Question: People with attention-deficit/hyperactivity disorder often have problems because they are impulsive ... (Read 72 times)

Evvie72

  • Hero Member
  • *****
  • Posts: 519
People with attention-deficit/hyperactivity disorder often have problems because they are impulsive and inattentive. The component of working memory that is most likely to be relevant in these problems is
 
  a. the episodic buffer.
  b. the central executive.
  c. the visuospatial sketchpad
  d. the phonological loop.

Question 2

In the working-memory model, which of the following cognitive activities would the central executive be most likely to perform?
 
  a. representing the information from a geometry problem
  b. deciding which items on a list should be remembered and which should be forgotten.
  c. actively transferring the information from working memory into sensory memory
  d. listening to a series of words in random order.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

macagnavarro

  • Sr. Member
  • ****
  • Posts: 334
Answer to Question 1

Ans: b

Answer to Question 2

Ans: b





 

Did you know?

On average, someone in the United States has a stroke about every 40 seconds. This is about 795,000 people per year.

Did you know?

Human kidneys will clean about 1 million gallons of blood in an average lifetime.

Did you know?

IgA antibodies protect body surfaces exposed to outside foreign substances. IgG antibodies are found in all body fluids. IgM antibodies are the first type of antibody made in response to an infection. IgE antibody levels are often high in people with allergies. IgD antibodies are found in tissues lining the abdomen and chest.

Did you know?

Vaccines prevent between 2.5 and 4 million deaths every year.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

For a complete list of videos, visit our video library